202 related articles for article (PubMed ID: 23840460)
1. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
Zhang Y; Chen MB; Zhou XY; Hong XN
PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
[TBL] [Abstract][Full Text] [Related]
3. LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study.
Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Kewan TZ
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2783-2791. PubMed ID: 32986381
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
[TBL] [Abstract][Full Text] [Related]
8. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
Chae YS; Kim JG; Sohn SK; Moon JH; Kim SN; Lee SJ; Park TI; Lee MH
Cancer Chemother Pharmacol; 2010 Feb; 65(3):571-7. PubMed ID: 19629486
[TBL] [Abstract][Full Text] [Related]
9. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
14. LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
Lin HY; Shi H; Li CY; Chen QC; Huang TB; Liu PC; Lou LM
J BUON; 2015; 20(1):261-8. PubMed ID: 25778326
[TBL] [Abstract][Full Text] [Related]
15. Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.
Tarabar O; Cikota-Aleksić B; Tukić L; Milanović N; Aleksić A; Magić Z
Int J Clin Oncol; 2014 Feb; 19(1):186-92. PubMed ID: 23532628
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
Gómez H; Hidalgo M; Casanova L; Colomer R; Pen DL; Otero J; Rodríguez W; Carracedo C; Cortés-Funes H; Vallejos C
J Clin Oncol; 1998 Jun; 16(6):2065-9. PubMed ID: 9626205
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N
Ann Oncol; 2007 Jan; 18(1):149-157. PubMed ID: 17018708
[TBL] [Abstract][Full Text] [Related]
18. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
[TBL] [Abstract][Full Text] [Related]
20. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]